View in EDS HTML Full Text PDF Full Text

Effectiveness and Safety of Tofacitinib Up to 36 Months in Canadian Patients with Rheumatoid Arthritis: Final Results from the CANTORAL Study.

Saved in:
Bibliographic Details
Title: Effectiveness and Safety of Tofacitinib Up to 36 Months in Canadian Patients with Rheumatoid Arthritis: Final Results from the CANTORAL Study.
Authors: Haraoui, Boulos1 (AUTHOR) haraouib@gmail.com, Choquette, Denis1 (AUTHOR), Sciortino, Cristina2 (AUTHOR), Galos, Corina2 (AUTHOR), Roy, Patrice2 (AUTHOR), Gruben, David3 (AUTHOR), Vaillancourt, Julie4 (AUTHOR), Sampalis, John S.5 (AUTHOR), Khraishi, Majed6 (AUTHOR)
Source: Rheumatology & Therapy. Jun2026, Vol. 13 Issue 3, p843-853. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21986576
DOI:10.1007/s40744-026-00854-1